Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09RKX
|
||||
Former ID |
DIB020767
|
||||
Drug Name |
PSB-11
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540990] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H17N5O
|
||||
InChI |
InChI=1S/C16H17N5O/c1-3-11-9-21-15(17-11)12-14(20(2)16(21)22)19-13(18-12)10-7-5-4-6-8-10/h4-8,11H,3,9H2,1-2H3,(H,18,19)/t11-/m1/s1
|
||||
InChIKey |
RGDHRCXUMURWBJ-LLVKDONJSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A1 receptor | Target Info | Antagonist | [526502] | |
Adenosine A2b receptor | Target Info | Antagonist | [526390] | ||
Adenosine A3 receptor | Target Info | Antagonist | [526260] | ||
Pathway Interaction Database | C-MYB transcription factor network | ||||
References | |||||
Ref 526260 | [(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors. Bioorg Med Chem Lett. 2002 Feb 11;12(3):501-3. | ||||
Ref 526390 | Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists. J Med Chem. 2002 Aug 1;45(16):3440-50. | ||||
Ref 526502 | 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors. Bioorg Med Chem. 2003 Feb 6;11(3):347-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.